K. Kavakli And A. Unuvar, "Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years," HAEMOPHILIA , vol.25, pp.28, 2019
Kavakli, K. And Unuvar, A. 2019. Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years. HAEMOPHILIA , vol.25 , 28.
Kavakli, K., & Unuvar, A., (2019). Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years. HAEMOPHILIA , vol.25, 28.
Kavakli, K., And Ayşegül ÜNÜVAR. "Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years," HAEMOPHILIA , vol.25, 28, 2019
Kavakli, K. And Unuvar, Ayşegül. "Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years." HAEMOPHILIA , vol.25, pp.28, 2019
Kavakli, K. And Unuvar, A. (2019) . "Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years." HAEMOPHILIA , vol.25, p.28.
@article{article, author={K. Kavakli And author={Ayşegül ÜNÜVAR}, title={Changing paradigma in Turkey: Plasma derived FVIII products have mostly preferred for pup patients in severe hemophilia-A for last two years}, journal={HAEMOPHILIA}, year=2019, pages={28} }